No Higher Infectivity But Immune Escape of SARS-CoV-2 501Y.V2 Variants
Qianqian Li(Peking Union Medical College Hospital), Youchun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruxia Ding(National Institutes for Food and Drug Control), Lingling Nie(China Electronics Standardization Institute), Qiong Lu(Huaihua University), Jiajing Wu(China Electronics Standardization Institute), Xiaowang Qu(University of South China), Yi Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Weijin Huang(National Institutes for Food and Drug Control), Yue Zhang(Beijing YouAn Hospital), Huan Liu(University of Hong Kong), Meng Wang(Shanghai University of Medicine and Health Sciences), Li Zhang(Chongqing University of Technology), Shuo Liu(Wuhan University), Xiaoyu Li(Academy of Military Medical Sciences), Haixin Wang(University of Electronic Science and Technology of China), Wenbo Xu(Shenyang Institute of Automation), Junkai Liu(China Electronics Standardization Institute), Haiyang Qin(China Electronics Standardization Institute), Liangzhi Xie(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianhui Nie(National Institutes for Food and Drug Control), Tao Li(PowerChina (China)), Haoyu Liang(Northwestern Polytechnical University), Linqi Zhang(Hebei University of Chinese Medicine), Yuelei Shen(Beijing Biocytogen (China)), Chenyan Zhao(National Institutes for Food and Drug Control)
Cited by 7
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study
|The Lancet Global Health|2020|1.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k